Lori Knudtson
Nurse Practitioner · Overland Park, KSNPI 1649265505
Payments from drug & device makers
Across 125 payments — averaging $17.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$609
- Abbott$301
- Pfizer$242
- Amgen$125
- Lilly USA, LLC$91
- Sumitomo Pharma America, Inc.$83
- plus $718 from 24 others
What the payments were for
- Food & beverage$2,170100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 34 | $609 |
| Abbott | 16 | $301 |
| Pfizer | 15 | $242 |
| Amgen | 8 | $125 |
| Lilly USA, LLC | 5 | $91 |
| Sumitomo Pharma America, Inc. | 5 | $83 |
| Novo Nordisk | 5 | $83 |
| Radius Health, Inc. | 3 | $68 |
| Boston Scientific | 2 | $53 |
| Johnson & Johnson | 3 | $47 |
| Bayer | 3 | $43 |
| Dynavax Technologies Corporation | 2 | $41 |
| Cequr Corporation | 2 | $40 |
| Dexcom, Inc. | 2 | $35 |
| Boehringer Ingelheim | 2 | $31 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $29 |
| AstraZeneca | 2 | $27 |
| Spinal Simplicity, LLC | 1 | $24 |
| Nevro Corp. | 1 | $24 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $23 |
| E.r. Squibb & Sons, L.L.C. | 1 | $21 |
| Ardelyx, Inc. | 1 | $17 |
| Teleflex LLC | 1 | $17 |
| Phathom Pharmaceuticals, Inc. | 1 | $17 |
| Xeris Pharmaceuticals, Inc. | 1 | $16 |
| Mylan Specialty L.p. | 1 | $14 |
| GSK | 1 | $14 |
| Esperion Therapeutics, Inc. | 1 | $14 |
| Amneal Pharmaceuticals LLC | 1 | $13 |
| Endogastric Solutions, Inc | 2 | $7 |
How this compares
$2,170 in reported general payments places this provider in the 85th percentile of 1,326 nurse practitioner providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 18 | $24,197 |
| MounjaroTirzepatide | 17 | $17,288 |
| EliquisApixaban | 14 | $11,742 |
| PaxlovidNirmatrelvir/Ritonavir | 14 | $1,331 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 12 | $417 |
| Pantoprazole Sodium | 20 | $321 |
| Losartan Potassium | 34 | $274 |
| Atorvastatin Calcium | 33 | $252 |
| Methylprednisolone | 32 | $232 |
| Doxycycline Hyclate | 25 | $211 |
| Gabapentin | 21 | $206 |
| ClopidogrelClopidogrel Bisulfate | 13 | $192 |
| Metoprolol Succinate | 12 | $179 |
| Levothyroxine Sodium | 15 | $173 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 14 | $133 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $83 | $24,19718 claims |
| Lilly USA, LLCMounjaro | $91 | $17,28817 claims |
| PfizerEliquis, Paxlovid | $242 | $13,07328 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $13 | $17315 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,326 nurse practitioner providers in Kansas.
Other nurse practitioner in Overland Park
- Morteza RabiiOverland Park$88K
- Diane GonzalezOverland Park$18K
- Brenda LaneOverland Park$14K
- Katelyn FreemanOverland Park$10K
- Stephanie LeeOverland Park$9K
- Jennifer KershnerOverland Park$7K
- Kimberly NagelOverland Park$6K
- Valentina AlmarazOverland Park$6K
- Jessica FoleyOverland Park$5K
- Gary GrafTopeka$726K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.